home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

FIGS, Inc. Class A Common Stock (NY:FIGS)

16.17 +0.11 (+0.68%)

Official Closing Price Updated: 7:00 PM EDT, Apr 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about FIGS, Inc. Class A Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

17 18 Next >

What 8 Analyst Ratings Have To Say About FIGS ↗

March 21, 2023

Via Benzinga

Meta Platforms To Rally Over 26%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

March 21, 2023

Morgan Stanley boosted the price target for HubSpot, Inc. (NYSE: HUBS) from $447 to $466. Morgan Stanley analyst Keith Weiss maintained an Overweight rating. HubSpot shares fell 1.9% to close at...

Via Benzinga

Figs Stock Is Down Nearly 90% From Its High. Time to Buy? ↗

March 11, 2023

The medical apparel maker faces tough near-term headwinds.

Via The Motley Fool

The Good News From Salesforce ↗

March 11, 2023

And we talk about people pulling back on spending on all those things that probably seemed essential in the earlier days of the pandemic.

Via The Motley Fool

$5M Bet On FIGS? Check Out These 3 Stocks Insiders Are Buying ↗

March 09, 2023

Although US stocks closed mixed on Wednesday, there were a few notable insider trades.

Via Benzinga

FIGS, Inc. (NYSE:FIGS) Long Term Investor Alert: Investigation of Potential Wrongdoing ↗

March 03, 2023

San Diego, CA -- (SBWIRE) -- 03/03/2023 -- An investigation on behalf of current long-term investors in shares of FIGS, Inc. (NYSE:FIGS) concerning potential breaches of fiduciary duties by certain...

Via SBWire

Analyst Ratings for FIGS ↗

March 01, 2023

Via Benzinga

Figs (FIGS) Q4 2022 Earnings Call Transcript ↗

February 28, 2023

FIGS earnings call for the period ending December 31, 2022.

Via The Motley Fool

Could Figs Stock Hit $20 in 2023? ↗

February 26, 2023

Reaching this lofty price target would certainly please investors.

Via The Motley Fool

FIGS Announces Participation in the KeyBanc Emerging Technology Summit

March 01, 2023

From FIGS, Inc.

Via Business Wire

Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 01, 2023

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.

Via Benzinga

Why Figs Stock Was Up This Week ↗

February 03, 2023

Easing inflation could be a big catalyst in 2023.

Via The Motley Fool

Expert Ratings for FIGS ↗

January 31, 2023

Via Benzinga

Down 75.6% in 2022, Is Figs Stock a Buy for 2023? ↗

January 19, 2023

The stylish healthcare apparel company has challenges to overcome.

Via The Motley Fool

Why Figs Stock Lost 76% in 2022 ↗

January 11, 2023

Slowing revenue growth torched shares of the healthcare apparel company.

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 01, 2023

Via Benzinga

FIGS Announces Participation in the Raymond James Institutional Investors Conference

March 01, 2023

From FIGS, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 01, 2023

Via Benzinga

Shares of Figs Inc. Are Trading Lower On Earnings Beat: What's Going On? ↗

February 28, 2023

Shares of Figs Inc (NYSE: FIGS) are trading lower into Tuesday’s after-market session following an earnings beat. Here’s what investors need to know.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 28, 2023

Via Benzinga

FIGS Releases Fourth Quarter and Full Year 2022 Financial Results

February 28, 2023

From FIGS, Inc.

Via Business Wire

SPI’s Litigation Against FIGS Is Over

February 22, 2023

From FIGS, Inc.

Via Business Wire

BAX: A “Hospital Stock” To Avoid ↗

February 20, 2023

Baxter International's shares are down nearly 50% over the past three years and have underperformed the broader healthcare industry.

Via Talk Markets

Retail Industry Veteran Steve Berube Joins FIGS as Chief Operating Officer and Devon Duff Gago Is Appointed Chief Business Development Officer

February 15, 2023

From FIGS, Inc.

Via Business Wire

FIGS Announces Date of Fourth Quarter and Full Year 2022 Earnings Release, Conference Call and Webcast

February 14, 2023

From FIGS, Inc.

Via Business Wire

2 Supercharged Stocks to Buy In 2023 That Could Double Your Money ↗

February 08, 2023

Don't let these stocks pass you by.

Via The Motley Fool

FIGS ALERT: Bragar Eagel & Squire, P.C. is Investigating FIGS, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

January 30, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

2 High-Growth Stocks That Are on Sale Now ↗

January 15, 2023

The market is not giving these rising stars the credit they deserve.

Via The Motley Fool

These 2 Stocks Are All-Stars In the Making ↗

January 12, 2023

Down 46% and 73% over the last year, these companies look poised to rebound as they eye international sales.

Via The Motley Fool

Skechers Not Nike Is The Sneaker Stock to Own for 2023

January 10, 2023

A tech-driven focus on comfort, omnichannel growth, international expansion and a low P/E are all good reasons to step into Skechers stock.

Via MarketBeat

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com